|
Revenue
|
|
$65.9m
|
$136.4m
|
$245.3m
|
$409.0m
|
$569.9m
|
$752.8m
|
$962.2m
|
|
Cost of revenue (including related party costs of $177,076, $231,803 and $302,910 for the years ended December 31, 2023, 2024 and 2025, respectively)
|
|
$47.2m
|
$92.9m
|
$153.8m
|
$250.9m
|
$336.3m
|
$413.3m
|
$525.9m
|
|
Gross profit
|
|
$18.7m
|
$43.5m
|
$91.4m
|
$158.2m
|
$233.6m
|
$339.4m
|
$436.2m
|
|
Research and development
|
|
$12.0m
|
$15.4m
|
$29.8m
|
$81.2m
|
$97.6m
|
$105.5m
|
$122.8m
|
|
Total operating expenses
|
|
$23.6m
|
$35.1m
|
$157.1m
|
$347.5m
|
$370.7m
|
$407.4m
|
$364.6m
|
|
Sales and marketing
|
|
$4.6m
|
$9.8m
|
$104.7m
|
$206.1m
|
$217.0m
|
$250.7m
|
$190.1m
|
|
General and administrative
|
|
$7.0m
|
$9.8m
|
$22.6m
|
$60.2m
|
$56.1m
|
$51.2m
|
$51.7m
|
|
Operating profit (loss)
|
|
($5.0m)
|
$8.4m
|
($65.7m)
|
($189.3m)
|
($137.1m)
|
($67.9m)
|
$71.7m
|
|
Profit (loss) before income taxes
|
|
($7.5m)
|
$4.1m
|
($74.2m)
|
($201.4m)
|
($131.8m)
|
($79.4m)
|
$70.5m
|
|
Provision for income taxes (benefits)
|
|
$34k
|
$160k
|
$705k
|
($6.0m)
|
$2.0m
|
($3.8m)
|
$2.2m
|
|
Net Income (loss)
|
|
($7.5m)
|
$3.9m
|
($74.9m)
|
($195.4m)
|
($133.8m)
|
($75.5m)
|
$68.3m
|
|
Net Income (loss) attributable to ordinary shareholders
|
|
($7.5m)
|
$725k
|
($74.9m)
|
($195.4m)
|
($133.8m)
|
($75.5m)
|
$68.3m
|
|
Net Income (loss) per share attributable to ordinary shareholders, basic
|
|
($0)
|
$0
|
($1)
|
($1)
|
($1)
|
($0)
|
$0
|
|
Net Income (loss) per share attributable to ordinary shareholders, diluted
|
|
($0)
|
$0
|
($1)
|
($1)
|
($1)
|
($0)
|
$0
|
|
Weighted-average shares used in computing net income (loss) per share attributable to ordinary shareholders, basic
|
|
($0)
|
$0
|
($1)
|
($1)
|
($1)
|
($0)
|
$0
|
|
Weighted-average shares used in computing net income (loss) per share attributable to ordinary shareholders, diluted
|
|
($0)
|
$0
|
($1)
|
($1)
|
($1)
|
($0)
|
$0
|
|
Financial expenses (income), net
|
|
$2.6m
|
$4.3m
|
$8.6m
|
$12.1m
|
($5.3m)
|
$11.5m
|
$1.2m
|